Cas:16889-14-8 n-[2-(diethylamino)ethyl]stearamide manufacturer & supplier

Chemical Name:n-[2-(diethylamino)ethyl]stearamide

CAS.NO:16889-14-8

Synonyms:N-[2-(diethylamino)ethyl]-Octadecanamide;Stearinsaeure-<2-diaethylamino-aethylamid>;N-(2-Diaethylamino-aethyl)-stearamid;n-[2-(diethylamino)ethyl]-octadecanamid;N-(2-diethylamino-ethyl)-stearamide;Octadecanamide,N-2-(diethylamino)ethyl;N-(2-(DIETHYLAMINO)ETHYL)STEARAMIDE;DIETHYLAMINOETHYLSTEARAMIDE;STEARAMIDOETHYL DIETHYLAMINE;EINECS 240-924-3

Molecular Formula:C₂₄H₅₀N₂O

Molecular Weight:382.66700

HS Code:2924199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:506.7ºC at 760 mmHg

Density:0.873 g/cm3

Index of Refraction:

PSA:32.34000

Exact Mass:382.39200

LogP:7.09680

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-[2-(diethylamino)ethyl]-Octadecanamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 240-924-3 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Octadecanamide,N-2-(diethylamino)ethyl Use and application,n-[2-(diethylamino)ethyl]-octadecanamid technical grade,usp/ep/jp grade.

Related News: The insulin-only and bihormonal configurations may be helpful in diabetes. n-[2-(diethylamino)ethyl]stearamide manufacturer A number of UK citizens had trouble reaching the muster point in time for the first flight out because of road blocks and other restrictions in place in Wuhan. n-[2-(diethylamino)ethyl]stearamide supplier The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. n-[2-(diethylamino)ethyl]stearamide vendor The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. n-[2-(diethylamino)ethyl]stearamide factory Schimpke, an assistant professor in the Division of Minimally Invasive and Bariatric Surgery at Rush Medical College in Chicago, and his colleagues point out that obesity is linked to a considerably higher risk for developing upwards of 40 different serious illnesses, including heart disease and diabetes.